Np mrd loader

Record Information
Version2.0
Created at2024-08-12 09:46:52 UTC
Updated at2024-09-16 10:47:02 UTC
NP-MRD IDNP0333729
Natural Product DOIhttps://doi.org/10.57994/3208
Secondary Accession NumbersNone
Natural Product Identification
Common Name6-O-ethylzephyranine E
Description It was first documented in 2024 (PMID: 39313750). Based on a literature review a significant number of articles have been published on 6-O-ethylzephyranine E (PMID: 39313741) (PMID: 39313725) (PMID: 39313684) (PMID: 39313682).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC20H29NO4
Average Mass347.4550 Da
Monoisotopic Mass347.20966 Da
IUPAC Name(1S,8S,10S,12S)-8-ethoxy-4,5,12-trimethoxy-9-azatetracyclo[7.5.2.0^{1,10}.0^{2,7}]hexadeca-2,4,6-triene
Traditional Name(1S,8S,10S,12S)-8-ethoxy-4,5,12-trimethoxy-9-azatetracyclo[7.5.2.0^{1,10}.0^{2,7}]hexadeca-2,4,6-triene
CAS Registry NumberNot Available
SMILES
[H][C@]12C[C@H](CC[C@@]11CCN2[C@@H](OCC)C2=CC(OC)=C(OC)C=C12)OC
InChI Identifier
InChI=1S/C20H29NO4/c1-5-25-19-14-11-16(23-3)17(24-4)12-15(14)20-7-6-13(22-2)10-18(20)21(19)9-8-20/h11-13,18-19H,5-10H2,1-4H3/t13-,18-,19-,20-/m0/s1
InChI KeyLRRYCKWQNAHRIL-KJYZGMDISA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
HMBC NMR[1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental)marikoj2@faf.cuni.czFaculty of Pharmacy, Charles UniversityJana Křoustková2024-08-12View Spectrum
NOESY NMR[1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental)marikoj2@faf.cuni.czFaculty of Pharmacy, Charles UniversityJana Křoustková2024-08-12View Spectrum
HSQC NMR[1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental)marikoj2@faf.cuni.czFaculty of Pharmacy, Charles UniversityJana Křoustková2024-08-12View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental)marikoj2@faf.cuni.czFaculty of Pharmacy, Charles UniversityJana Křoustková2024-08-12View Spectrum
H2BC NMR[1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental)marikoj2@faf.cuni.czFaculty of Pharmacy, Charles UniversityJana Křoustková2024-08-12View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental)marikoj2@faf.cuni.czFaculty of Pharmacy, Charles UniversityJana Křoustková2024-08-12View Spectrum
COSY NMR[1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental)marikoj2@faf.cuni.czFaculty of Pharmacy, Charles UniversityJana Křoustková2024-08-12View Spectrum
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
citrina
      Not Available
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP2.65ChemAxon
pKa (Strongest Basic)7.41ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area40.16 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity96.62 m³·mol⁻¹ChemAxon
Polarizability39.51 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Chen Z, Li X, Xu G, Xiao T, Wang D, Wang C, Zhang K, Li J, Pan Y, Qiao Y, Zhang Y: Synergize Strong and Reactive Metal-Support Interactions to Construct Sub-2 nm Metal Phosphide Cluster for Enhanced Selective Hydrogenation Activities. Angew Chem Int Ed Engl. 2024 Sep 23:e202413788. doi: 10.1002/anie.202413788. [PubMed:39313750 ]
  2. Hirai T, Aoyama T, Tsuji Y, Ino K, Ikejiri M, Tawara I, Iwamoto T: Pharmacokinetic Model of Drug Interaction of Tacrolimus with Combined Administration of CYP3A4 Inhibitors Voriconazole and Clarithromycin After Bone Marrow Transplantation. Eur J Drug Metab Pharmacokinet. 2024 Sep 24. doi: 10.1007/s13318-024-00915-2. [PubMed:39313741 ]
  3. Beghini A, Aimo A, Ambrosy AP, Tomasoni D: Modulating energy metabolism to treat non-obstructive hypertrophic cardiomyopathy? Insights from IMPROVE-HCM. Heart Fail Rev. 2024 Sep 23. doi: 10.1007/s10741-024-10440-8. [PubMed:39313725 ]
  4. Frank S, Lessa Derci Augustynczik A, Havlik P, Boere E, Ermolieva T, Fricko O, Di Fulvio F, Gusti M, Krisztin T, Lauri P, Palazzo A, Wogerer M: Enhanced agricultural carbon sinks provide benefits for farmers and the climate. Nat Food. 2024 Sep;5(9):742-753. doi: 10.1038/s43016-024-01039-1. Epub 2024 Sep 23. [PubMed:39313684 ]
  5. Mills ES, Wang JC, Richardson MK, Chung BC, Mayer LW, Gallo MC, Alluri RK, Hah RJ, Heckmann ND: The change in lumbar lordosis from the standing to the lateral position: implications for lateral interbody fusion. Eur Spine J. 2024 Sep 23. doi: 10.1007/s00586-024-08493-2. [PubMed:39313682 ]